Andy Chen Selected Research

Infections

1/2022	The Role of Targeted Versus Standard Antibiotic Prophylaxis in Pancreatoduodenectomy in Reducing Postoperative Infectious Complications: A Systematic Review and Meta-analysis.
11/2020	New cross-linkable poly[bis(octafluoropentoxy) phosphazene] biomaterials: Synthesis, surface characterization, bacterial adhesion, and plasma coagulation responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andy Chen Research Topics

Disease

13	Neoplasms (Cancer) 01/2024 - 06/2004
5	Neoplasm Metastasis (Metastasis) 11/2022 - 01/2014
4	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2017
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 01/2016
2	Infections 01/2022 - 11/2020
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 03/2017
2	Wounds and Injuries (Trauma) 01/2022 - 12/2018
2	Bone Resorption 02/2018 - 01/2018
2	Hodgkin Disease (Hodgkin's Disease) 12/2016 - 01/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2024
1	Pathologic Complete Response 05/2024
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2023
1	Surgical Wound Infection 01/2022
1	Lymphoma (Lymphomas) 07/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Thrombosis (Thrombus) 11/2020
1	Job Syndrome (Hyper-IgE Syndrome) 01/2020
1	Bone Diseases (Bone Disease) 01/2020
1	Insulin Resistance 09/2018
1	Disease Susceptibility (Diathesis) 09/2018
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018
1	Bone Fractures (Bone Fracture) 01/2018
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2017
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2016
1	Inflammation (Inflammations) 04/2015
1	Arthritis (Polyarthritis) 04/2015
1	Virus Diseases (Viral Diseases) 01/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2014
1	Melanoma (Melanoma, Malignant) 01/2014
1	Disease Progression 01/2014
1	Uveal melanoma 01/2014
1	Osteoporosis 07/2013
1	Chondrosarcoma 09/2012
1	Food Hypersensitivity (Food Allergy) 01/2006
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2004

Drug/Important Bio-Agent (IBA)

4	Conditioned Culture MediaIBA 01/2024 - 01/2018
3	Chimeric Antigen ReceptorsIBA 05/2024 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 11/2023 - 06/2004
3	Dopamine Receptors (Dopamine Receptor)IBA 11/2022 - 01/2017
3	salubrinalIBA 04/2015 - 09/2012
2	CytokinesIBA 01/2024 - 04/2015
2	VinculinIBA 01/2024 - 01/2019
2	Volatile Organic CompoundsIBA 01/2020 - 12/2019
2	Transcription Factors (Transcription Factor)IBA 12/2019 - 01/2018
2	RNA (Ribonucleic Acid)IBA 12/2018 - 01/2018
2	Phosphotransferases (Kinase)IBA 09/2018 - 06/2004
2	NFATC Transcription FactorsIBA 09/2018 - 01/2018
2	PD 407824IBA 09/2018 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 02/2018 - 01/2017
2	CollagenIBA 01/2018 - 04/2015
2	Brentuximab VedotinIBA 12/2016 - 01/2016
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2024
1	ibrutinibIBA 01/2023
1	obinutuzumabIBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 07/2021
1	Biocompatible Materials (Biomaterials)IBA 11/2020
1	poly(bis(octafluoropentoxy)phosphazene)IBA 11/2020
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2020
1	OsteopontinIBA 01/2020
1	pitavastatin (itavastatin)FDA Link 12/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2019
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2019
1	Mevalonic Acid (Mevalonate)IBA 12/2019
1	CholesterolIBA 12/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2019
1	Bone Morphogenetic Protein 2IBA 12/2019
1	DioxinsIBA 09/2018
1	Endocrine DisruptorsIBA 09/2018
1	3- (carbamoylamino)- 5- (3- fluorophenyl)- N- (3- piperidyl)thiophene- 2- carboxamideIBA 09/2018
1	Checkpoint Kinase 1IBA 02/2018
1	Collagen Type I (Type I Collagen)IBA 01/2018
1	Dopamine (Intropin)FDA LinkGeneric 01/2018
1	ElementsIBA 01/2018
1	Fluphenazine (Prolixin)FDA LinkGeneric 01/2018
1	Sepharose (Agarose)IBA 01/2018
1	Trifluoperazine (Stelazine)FDA LinkGeneric 01/2018
1	BiglycanIBA 01/2018
1	Rituximab (Mabthera)FDA Link 03/2017
1	pinatuzumab vedotinIBA 03/2017
1	Immunoconjugates (Immunoconjugate)IBA 03/2017
1	A 77636IBA 01/2017
1	S100 Calcium-Binding Protein A4IBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Prokaryotic Initiation Factor-2IBA 01/2015
1	CalciumIBA 10/2014
1	RANK LigandIBA 07/2013
1	Peptide Initiation Factors (Initiation Factor)IBA 09/2012
1	Immunoglobulin E (IgE)IBA 01/2006
1	Epidermal Growth Factor (EGF)IBA 06/2004

Therapy/Procedure

2	Therapeutics 05/2024 - 01/2022
2	Drug Therapy (Chemotherapy) 01/2024 - 09/2018
2	Radiotherapy 01/2014 - 09/2012
1	Immunotherapy 11/2023
1	Pancreaticoduodenectomy 01/2022
1	Antibiotic Prophylaxis 01/2022
1	Autologous Transplantation 01/2018
1	Homologous Transplantation 01/2018
1	Cell Transplantation 01/2016
1	Brachytherapy 01/2014